Clinical trialNCT04758299CompletedInterventional

Understanding Communications Included With COVID-19 (Corona Virus Disease of 2019) Home Testing Kits

SponsorBarry DewittEnrollment360COVID-19 TestingDecision Making

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To test competing sets of information for consumers on how to interpret hypothetical SARS-CoV-2 home test kit results and whether they report plans to take CDC-recommended actions to protect themselves and others given their test results and two critical aspects of their clinical context: symptoms, recent close exposures. Participants will be randomized to receive either information from the FDA authorized Ellume home test kit (the first kit authorized for over the counter use) for what actions to take for a negative or positive COVID-19 test (usual care) or a decision science-based design of similar length (intervention).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Barry Dewitt
Carnegie Mellon University
Principal Investigator
clinicaltrials.gov ↗
Baruch Fischhoff, PhD
Carnegie Mellon University
Principal Investigator
clinicaltrials.gov ↗
Steven Woloshin, MD
Dartmouth College
Principal Investigator
clinicaltrials.gov ↗
Tamar Krishnamurti, PhD
University of Pittsburgh
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Carnegie Mellon University
Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 13 Mar 2021
Primary completion: 15 Apr 2021
Completion: 30 Apr 2021
Last update posted: 25 May 2021
Registered enrollment: 360
Registry id: NCT04758299

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 11 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.